Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions [Yahoo! Finance]
DAIICHI SANKYO S/ADR (DSNKY)
NASDAQ:AMEX Investor Relations:
daiichisankyo.com/media_investors/investor_relations/index.html
Company Research
Source: Yahoo! Finance
The agreement involves Daiichi Sankyo Research Institute Boston and aims to assess the use of Interna's MNM technology as a delivery enhancer for therapeutic modalities. Interna's MNM molecules will be integrated with targeting approaches for enhancing functional activity, intracellular delivery and overall therapeutic performance in selected programmes. The agreement also allows for potential expansion into wider research and further programmes if outcomes prove successful. The partnership indicates ongoing interest in MNM-based platforms among global pharmaceutical companies and adds to Interna Therapeutics' existing collaborations. MNM technology is designed to achieve efficient intracellular delivery of different therapeutic cargos, such as nucleic acids and other macromolecules, without the dependence on traditional delivery systems. By improving both tissue penetration and intracellular access, it could potentially enhance the efficacy of targeted therapies throughout
Show less
Read more
Impact Snapshot
Event Time:
DSNKY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DSNKY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DSNKY alerts
High impacting DAIICHI SANKYO S/ADR news events
Weekly update
A roundup of the hottest topics
DSNKY
News
- Merck's Priority Review Cancer Drug Adds To Undervalued Growth Story [Yahoo! Finance]Yahoo! Finance
- Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery Technologies [Yahoo! Finance]Yahoo! Finance
- Interna Therapeutics Announces Research Collaboration with Daiichi Sankyo to Advance MNM-Based Targeted Delivery TechnologiesPR Newswire
- Wayfinder Biosciences Advances Collaboration with Daiichi Sankyo on Key Neurodegeneration Target to Second Phase [Yahoo! Finance]Yahoo! Finance
- Wayfinder Biosciences Advances Collaboration with Daiichi Sankyo on Key Neurodegeneration Target to Second Phase [TheStreet.com]TheStreet.com